SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2003
Introgen Therapeutics, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-21291 74-2704230
----------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
301 Congress Avenue, Suite 1850, Austin, Texas 78701
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (512) 708-9310
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press Release dated August 12, 2003.
Item 12. Results of Operations and Financial Condition.
Attached hereto as Exhibit 99.1 and incorporated by reference herein is
the text of the registrant's press release, dated August 12, 2003, regarding
results of operations and financial condition for the registrant's second fiscal
quarter ended June 30, 2003.
The information in this Current Report on Form 8-K is being furnished and
shall not be deemed "filed" for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: August 12, 2003 INTROGEN THERAPEUTICS, INC.
/s/ James W. Albrecht, Jr.
-------------------------------------
James W. Albrecht, Jr.
Chief Financial Officer
-2-
INDEX TO EXHIBITS
Exhibit
Number Description of Document
------ -----------------------
99.1 Press Release dated August 12, 2003.